To the full analysis
Buyback calculator for Novozymes
Novozymes stock: key metrics
NSIS-B.CONovozymes had an operating margin of 21.2% and a return on invested capital (ROIC) of 3% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2006 | 53.7% | 19.7% | 1.8% |
| 2007 | 51.4% | 18.6% | 14.1% |
| 2008 | 53.5% | 18.5% | 13.0% |
| 2009 | 7.2% | 20.0% | 1.9% |
| 2010 | 55.7% | 21.8% | 16.6% |
| 2011 | 54.3% | 22.1% | 17.4% |
| 2012 | 57.2% | 3.2% | 17.9% |
| 2013 | 57.2% | 24.7% | 18.7% |
| 2014 | 57.4% | 27.2% | 20.3% |
| 2015 | 58.1% | 27.7% | 20.2% |
| 2016 | 57.5% | 27.9% | 21.6% |
| 2017 | 57.9% | 27.9% | 21.5% |
| 2018 | 57.4% | 28.3% | 22.4% |
| 2019 | 55.3% | 28.1% | 21.9% |
| 2020 | 56.0% | 26.1% | 20.2% |
| 2021 | 57.7% | 26.8% | 21.0% |
| 2022 | 54.6% | 26.4% | 20.9% |
| 2023 | 54.3% | 25.4% | 16.9% |
| 2024 | 47.2% | 17.2% | 8.0% |
| 2025 | 53.9% | 21.2% | 14.0% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2006 | 27.1% | 28.0% | 11.5% |
| 2007 | 28.7% | 6.5% | 11.9% |
| 2008 | 23.8% | 50.0% | 80.3% |
| 2009 | 20.5% | 69.7% | 1.5% |
| 2010 | 153.9% | 164.7% | 95.6% |
| 2011 | 20.7% | 19.8% | 13.2% |
| 2012 | 21.1% | 4.4% | 99.5% |
| 2013 | 19.9% | 19.9% | 13.3% |
| 2014 | 22.4% | 23.3% | 13.7% |
| 2015 | 24.4% | 26.8% | 15.9% |
| 2016 | 26.0% | 25.0% | 16.3% |
| 2017 | 27.7% | 25.4% | 17.0% |
| 2018 | 28.2% | 24.8% | 16.4% |
| 2019 | 27.5% | 22.8% | 15.4% |
| 2020 | 25.1% | 19.4% | 13.8% |
| 2021 | 3.6% | 3.3% | 1.7% |
| 2022 | 3.6% | 3.2% | 1.8% |
| 2023 | 21.6% | 17.2% | 10.7% |
| 2024 | 2.7% | 2.9% | 2.0% |
| 2025 | 5.4% | 3.0% | 3.6% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = DKK 6.7461, $1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 3 Jul 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.